Schedule of Comparison of Basic and Fully Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Net loss - before noncontrolling interest	$ (56,126)	$ (35,888)
Net loss attributable to noncontrolling interest	5,779	1,612
Net loss - as reported, attributable to PAVmed Inc.	(50,347)	(34,276)
Series B Convertible Preferred Stock dividends – earned(1)	(283)	(287)
Net loss attributable to PAVmed Inc. common stockholders	$ (50,630)	$ (34,563)
Weighted average common shares outstanding, basic and diluted(2)	77,515,767	47,432,115
Net loss - as reported, attributable to PAVmed Inc.	$ (0.65)	$ (0.72)
Net loss attributable to PAVmed Inc. common stockholders	$ (0.65)	$ (0.73)